Nikhil Kumar is a content writer with a diverse range of writing experience. He has written for publications such as The Messenger and TechSling Online, and his work has been featured in Grid, The Independent, Cureus Journal of Medical Science, and Nature Portfolio. Nikhil covers a wide range of topics, including politics, entertainment, technology, and current events.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Nikhil Kumar's articles cover a wide range of topics including politics, international relations, technology, entertainment, and war and conflict. With a focus on evolving stories and breaking news related to government & politics as well as entertainment news, Nikhil is likely interested in receiving pitches that offer unique perspectives or insights into ongoing events.
Given his coverage attributes which emphasize evolving stories and breaking news across diverse themes such as politics, international relations, technology, entertainment, war and conflict; he may be more responsive to sources who can provide timely commentary on unfolding events within these areas. This could include experts with first-hand knowledge of political developments or individuals directly involved in the industries covered.
As Nikhil does not have a specific geographic focus mentioned but covers global elections and international relations extensively making him open for contributions from around the world.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Nikhil Kumar
Sizzling Samachar of the Day - 25th September 2024
Sizzling Samachar of the Day - 3rd October 2024
By: Nikhil Kumar
Sizzling Samachar of the Day - 15th October 2024
By: Nikhil Kumar
Russell plays a suave, larger-than-life criminal in this underrated heist movie
If dark, twisty plots and morally gray characters are your jam, then buckle up for Do Patti
By: Nikhil Kumar
This guide provides a walkthrough for the “Pwned1” box, focusing on reconnaissance, enumeration, exploitation, and privilege escalation to…
The forgotten masterpiece Cloverfield is the best monster movie you’ve not watched yet
Why Mama is a lot more than a ghost story: Watch online
By: Natarajan Shivkadaksham, Nikhil Kumar, C K. Ponde, Dheeraj Gandotra, Sn Routray, Sunil Sathe, S N Routray, Jagdish Hiremath, Rajat Sharma, Govindan Unni, Prakash Hazra, Dheeraj Gandotra, Chandrashekhar Makhale, Bijay P. Pandey
Home time, defined as time spent by the patient alive and out of any healthcare institution, is an important patient-centric outcome for patients with cardiovascular disease. Home time is recognized as a crucial measure of recovery post cardiovascular events but has not been extensively studied in heart failure (HF) patients, especially in India. HF in India is rapidly growing at an epidemic scale and hence the focus on improving home time in HF patients highlights the need for precise, patient-centered care strategies. Current literature lacks detailed descriptions of hospital-level patterns and predictors of home time in contemporary HF populations, which hinders tailored approaches to optimize outcomes like functional status and health-related quality of life along with reduced hospitalization and mortality risks. Literature is abundant with clinical evidence on the benefits of guideline-directed medical therapy (GDMT), especially angiotensin receptor neprilysin inhibitor (ARNI) therapy, in HF management. All major guidelines highly recommend its initiation for reducing morbidity and mortality in patients with chronic symptomatic HF with reduced ejection fraction. Studies indicate that sacubitril/valsartan, the first in class of ARNI, improves the quality of life and functional outcomes, along with reduced HF-related hospitalizations and cardiovascular deaths. Its unique mechanism of action, combining neprilysin inhibition and angiotensin receptor blockade, targets multiple pathways of HF pathophysiology, leading to improved cardiac function and remodeling. These benefits are pivotal in supporting patients' ability to maintain an active lifestyle outside of healthcare settings. Despite its demonstrated benefits, sacubitril/valsartan is underutilized. Integrating sacubitril/valsartan more optimally into clinical practice could significantly alleviate the overall burden of HF by addressing key determinants of home time and improving patient outcomes post discharge.
By: Nikhil Kumar
Sizzling Samachar of the Day - 12th November 2024
(833) 317-6278 
